168 related articles for article (PubMed ID: 33356997)
21. Qualitative age interactions between low-grade and high-grade serous ovarian carcinomas.
Grimley PM; Matsuno RK; Rosenberg PS; Henson DE; Schwartz AM; Anderson WF
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2256-61. PubMed ID: 19622723
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis-shift between low-grade serous ovarian cancer and serous borderline ovarian tumor: A population-based study.
Matsuo K; Machida H; Grubbs BH; Matsuzaki S; Klar M; Roman LD; Sood AK; Gershenson DM
Gynecol Oncol; 2020 Apr; 157(1):21-28. PubMed ID: 31954535
[TBL] [Abstract][Full Text] [Related]
23. [Construction and utilization of the prognostic model of serous ovarian adenocarcinoma].
Yang R; Feng J; Fang XZ; Bai F; Cheng YX; Liu C; Zhu W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):459-63. PubMed ID: 17083811
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and prognosis of synchronous distant metastatic tonsil squamous cell carcinomas.
Li Y; Hu C
Int J Med Sci; 2021; 18(2):528-533. PubMed ID: 33390822
[TBL] [Abstract][Full Text] [Related]
25. A comprehensive prognostic analysis of cause-specific mortality in patients with ovarian serous cystadenocarcinoma using a competing-risks model: a case study of the SEER database.
Chong SM; Li YJ; He Y; Chokkakula S; Ming WK; Leong NC; Zhao QQ; Chen WH; Huang CD; Deng LH; Lyu J
Eur Rev Med Pharmacol Sci; 2023 Nov; 27(22):11143-11155. PubMed ID: 38039046
[TBL] [Abstract][Full Text] [Related]
26. A High-Quality Nomogram for Predicting Lung Metastasis in Newly Diagnosed Stage IV Thyroid Cancer: A Population-Based Study.
Wang W; Liu J; Xu X; Huo L; Wang X; Gu J
Technol Cancer Res Treat; 2023; 22():15330338231167807. PubMed ID: 37038628
[No Abstract] [Full Text] [Related]
27. Patterns of bone metastases in newly diagnosed colorectal cancer: a real-world analysis in the SEER database.
Guo X; Zhang C; Ma W; Tian F; Xu G; Han X; Sun P; Baklaushev VP; Bryukhovetskiy AS; Wang G; Ma Y; Wang X
Int J Colorectal Dis; 2019 Mar; 34(3):533-543. PubMed ID: 30617414
[TBL] [Abstract][Full Text] [Related]
28. Survival of Patients With Mucinous Ovarian Carcinoma and Ovarian Metastases: A Population-Based Cancer Registry Study.
Simons M; Ezendam N; Bulten J; Nagtegaal I; Massuger L
Int J Gynecol Cancer; 2015 Sep; 25(7):1208-15. PubMed ID: 25978291
[TBL] [Abstract][Full Text] [Related]
29. The preoperative prognostic nutritional index is a predictive and prognostic factor of high-grade serous ovarian cancer.
Feng Z; Wen H; Ju X; Bi R; Chen X; Yang W; Wu X
BMC Cancer; 2018 Sep; 18(1):883. PubMed ID: 30200903
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary metastasis in newly diagnosed colon-rectal cancer: a population-based nomogram study.
Huang Y; Zhao M; Yin J; Lu T; Yang X; Yuan G; Li M; Liu Y; Zhan C; Wang Q
Int J Colorectal Dis; 2019 May; 34(5):867-878. PubMed ID: 30854572
[TBL] [Abstract][Full Text] [Related]
31. Poorer prognosis of ovarian squamous cell carcinoma than serous carcinoma: a propensity score matching analysis based on the SEER database.
Zhang C; Ma T
J Ovarian Res; 2020 Jul; 13(1):75. PubMed ID: 32611433
[TBL] [Abstract][Full Text] [Related]
32. The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry.
Mattes MD; Lee JC; Metzger DJ; Ashamalla H; Katsoulakis E
J Gynecol Oncol; 2015 Jan; 26(1):19-24. PubMed ID: 25310855
[TBL] [Abstract][Full Text] [Related]
33. The prognostic analysis of different metastatic patterns in advanced liver cancer patients: A population based analysis.
Chen J
PLoS One; 2018; 13(8):e0200909. PubMed ID: 30102707
[TBL] [Abstract][Full Text] [Related]
34. Lung and bone metastases patterns in osteosarcoma: Chemotherapy improves overall survival.
Tang L; Liu B
Medicine (Baltimore); 2023 Jan; 102(4):e32692. PubMed ID: 36705375
[TBL] [Abstract][Full Text] [Related]
35. Analysis of Homogeneous and Heterogeneous Factors for Bone Metastasis in Esophageal Cancer.
Zhang J; Ma W; Wu H; Wang J; Lin Y; Wang X; Zhang C
Med Sci Monit; 2019 Dec; 25():9416-9425. PubMed ID: 31821313
[TBL] [Abstract][Full Text] [Related]
36. Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease - a Swedish Gynecologic Cancer Group (SweGCG) study.
Hjerpe E; Staf C; Dahm-Kähler P; Stålberg K; Bjurberg M; Holmberg E; Borgfeldt C; Tholander B; Hellman K; Kjølhede P; Högberg T; Rosenberg P; Åvall-Lundqvist E
Acta Oncol; 2018 Mar; 57(3):331-337. PubMed ID: 29130381
[TBL] [Abstract][Full Text] [Related]
37. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
[TBL] [Abstract][Full Text] [Related]
38. SALL4 is a marker of poor prognosis in serous ovarian carcinoma promoting invasion and metastasis.
Yang M; Xie X; Ding Y
Oncol Rep; 2016 Mar; 35(3):1796-806. PubMed ID: 26750614
[TBL] [Abstract][Full Text] [Related]
39. Validation of a two-tier grading system in an unselected, consecutive cohort of serous ovarian cancer patients.
Battista MJ; Cotarelo C; Almstedt K; Heimes AS; Makris GM; Weyer V; Schmidt M
Arch Gynecol Obstet; 2016 Sep; 294(3):599-606. PubMed ID: 26993518
[TBL] [Abstract][Full Text] [Related]
40. Early onset neutropenia: a useful predictor of chemosensitivity and favorable prognosis in patients with serous ovarian cancer.
He Y; Li T; Liu J; Ou Q; Zhou J
BMC Cancer; 2020 Feb; 20(1):116. PubMed ID: 32050944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
